RNF168 may stabilize STAT1 protein, which is a core component of the JAK-STAT signaling pathway, by inhibiting the polyubiquitination of STAT1, and thus promote the proliferation and invasion of esophageal cancer cells by activating the JAK-STAT signaling pathway [63,64]. This evidence concerns the gene STAT1 and esophageal cancer.